Cardiology Step 2 CK: A Complete Review of the Topics That Matter
Cardiology is the highest-yield organ system on Step 2 CK. The USMLE content outline allocates 6 to 12 percent of items to the cardiovascular system, and because most of those questions fall under the Medicine discipline, the practical footprint is even larger. Students who treat cardiology Step 2 CK as a secondary priority consistently underscore its relative importance to their overall preparation level. This is not a system to round on lightly.
What follows is a working review of the six domains that generate the most exam questions in cardiology Step 2 CK. The goal is to clarify management logic, not pad your reading list. At the end of each section, there are specific notes for students who are scoring above target and want to tighten up, and for students who are below target and need a more stabilizing approach.
ACS Management Algorithm
The exam will give a patient with chest pain and ask what to do next. In cardiology Step 2 CK, the answer always depends on three things: what the ECG shows, what the troponin shows, and how hemodynamically stable the patient is.
An ECG within 10 minutes of arrival comes before anything else. That single step determines the entire branch of the algorithm. If ST elevation is present in two or more contiguous leads (or a new left bundle branch block appears), this is a STEMI. The goal is reperfusion. Primary PCI is preferred, with a door-to-balloon target of under 90 minutes. If PCI is not available within roughly 120 minutes of first medical contact, fibrinolytics go in within 30 minutes of arrival, assuming no contraindications. STEMI management does not wait for troponin results.
NSTEMI and unstable angina look similar on presentation: ischemic symptoms without ST elevation. What separates them is troponin. NSTEMI has an elevated troponin. Unstable angina does not. Both receive the same initial medical therapy, and most patients undergo angiography within 24 hours. Immediate angiography is reserved for patients with hemodynamic instability, refractory ischemia, or new heart failure.
Universal initial therapy for ACS includes aspirin (chew 162 to 325 mg), a P2Y12 inhibitor (ticagrelor or prasugrel preferred over clopidogrel when PCI is planned), anticoagulation with heparin, a high-intensity statin, and a beta-blocker unless contraindicated. Oxygen only if the patient is hypoxic. Withhold beta-blockers in acute decompensated heart failure, bradycardia, or cardiogenic shock.
→ Reperfusion
≥ 2 leads?
Check troponin
Aspirin 162–325 mg · P2Y12 inhibitor · Heparin
High-intensity statin · Beta-blocker (if no contraindication) O₂ only if hypoxic · Hold beta-blocker in decompensated HF / bradycardia / shock
! Classic Trap
Right ventricular infarction occurs with inferior STEMI (ST elevation in II, III, aVF). These patients are preload-dependent. Nitrates drop preload and can precipitate circulatory collapse. Confirm with right-sided lead V4R. Treat hypotension with IV fluids, not vasodilators.
If Scoring Above Target
Focus on the edge cases: posterior MI (tall R in V1 with ST depression, confirmed on V7–V9), cocaine-induced vasospasm (nitroglycerin and benzodiazepines, not beta-blockers), and the distinction between thrombolytics and PCI indications when transfer time is explicitly stated in the vignette.
If Scoring Below Target
Lock down the basic algorithm before anything else. STEMI: ECG first, reperfusion decision, door-to-balloon under 90 minutes. NSTEMI/UA: troponin distinguishes them, same initial therapy, angiography within 24 hours. Getting these right accounts for most of the ACS points on the exam.
Heart Failure: HFrEF vs. HFpEF Workup and Treatment
Heart failure questions on the high yield cardiology USMLE pool almost always test one of two things: which drug improves survival in HFrEF, or what to do with a patient in acute decompensation. The first distinction to make is ejection fraction. HFrEF is EF at or below 40 percent. HFpEF is EF at or above 50 percent with evidence of elevated filling pressures. Echocardiography confirms both. Most Step 2 CK questions concern HFrEF because the guideline-directed therapy is more specific and more frequently tested. The 2022 AHA/ACC/HFSA guideline organizes HFrEF treatment around four drug classes, all with Class 1 recommendations:
ARNI
Sacubitril / valsartan
Preferred over ACEi/ARB. Never combine with ACEi — 36-hr washout required.
Beta-Blocker
Carvedilol, metoprolol succinate, bisoprolol
Only these 3 have mortality data. Do not start during acute decompensation.
MRA
Spironolactone, eplerenone
Monitor potassium. Avoid in significant renal impairment or hyperkalemia.
SGLT2 Inhibitor
Dapagliflozin, empagliflozin
Class 1A regardless of diabetes. Also Class 2a in HFpEF.
Loop diuretics (furosemide) relieve congestion and improve symptoms but do not reduce mortality. When a question asks which drug improves survival, loop diuretics are never the answer.
For acute decompensated heart failure, the priority is decongestion. IV furosemide is the workhorse. Oxygen and upright positioning for respiratory distress. Nitrates for afterload reduction when blood pressure allows. Do not uptitrate or initiate beta-blockers while the patient is volume overloaded.
⚠ Loop Diuretic Trap
Loop diuretics relieve symptoms but do not improve survival. On any question asking which drug reduces mortality in HFrEF, furosemide is a distractor. The four pillars are the only agents with mortality benefit.
If Scoring Above Target
Know that SGLT2 inhibitors carry a Class 2a recommendation even in HFpEF, understand which three beta-blockers specifically have mortality data, and recognize high-output heart failure presentations (severe anemia, thyrotoxicosis, AV fistula) before reaching for the standard algorithm.
If Scoring Below Target
Drill the four drug classes with mortality benefit in HFrEF. Then memorize what loop diuretics do not do. Most heart failure questions below the 220 range are testing this single concept. Get it clean before moving to edge cases.
Valvular Disease: When to Refer for Surgery
Valvular questions almost always hinge on one of two things: identifying the lesion from a murmur description or knowing when surgery is indicated.
Aortic Stenosis
SYSTOLICAortic Regurgitation
DIASTOLICMitral Stenosis
DIASTOLICMitral Regurgitation
SYSTOLIC✓ Maneuver Logic
Most left-sided murmurs increase with maneuvers that increase preload (squatting, passive leg raise) and decrease with Valsalva or standing. Hypertrophic cardiomyopathy and mitral valve prolapse are the exceptions. Both become louder with decreased preload (Valsalva, standing) and quieter with squatting or handgrip. This distinction appears regularly in the Step 2 CK cardiology review question pool.
Arrhythmias: A-Fib, SVT, and When to Cardiovert
Arrhythmia questions in the high yield cardiology USMLE section cluster around three scenarios: rate versus rhythm control decisions in atrial fibrillation, management of SVT, and ACLS shockable rhythms.
Atrial Fibrillation
Rate control is the default for most patients: beta-blocker or a non-dihydropyridine CCB (diltiazem or verapamil). Avoid non-dihydropyridine CCBs in HFrEF because of their negative inotropic effect. Rhythm control is preferred in younger, symptomatic patients and in those with newly diagnosed AF.
! WPW Trap
In Wolff-Parkinson-White syndrome with atrial fibrillation, AV nodal blockers (adenosine, beta-blockers, CCBs, digoxin) are contraindicated. They block the AV node and accelerate conduction down the accessory pathway, which can precipitate ventricular fibrillation. Use procainamide or cardioversion.
SVT and ACLS Rhythms
Stable SVT: vagal maneuvers first, then adenosine 6 mg IV (may repeat at 12 mg). Unstable SVT: synchronized cardioversion. Ventricular fibrillation and pulseless ventricular tachycardia are the two shockable arrest rhythms. Immediate defibrillation, high-quality CPR, epinephrine every three to five minutes, and amiodarone 300 mg after the third shock for refractory VF or pulseless VT. PEA and asystole are not shockable. They get epinephrine and treatment of reversible causes.
Heart block management is a source of frequent mistakes. Mobitz I (Wenckebach) is usually benign. Mobitz II and third-degree AV block carry a high risk of progression and require pacemaker placement. Atropine is often ineffective in Mobitz II and complete heart block because the lesion is below the AV node.
If Scoring Above Target
Focus on torsades de pointes (prolonged QT, polymorphic VT, causes, treatment with magnesium), long QT syndrome drug list, and the distinction between appropriate and inappropriate ICD shocks. These appear less frequently but reward careful review.
If Scoring Below Target
Prioritize the cardioversion timing rule for AF, the WPW contraindication list, and the shockable versus non-shockable algorithm. These three areas generate a disproportionate share of arrhythmia questions. Get them correct before spending time on atrial flutter wave ratios or aberrant conduction patterns.
Free Consultation — No Commitment
If cardiology Step 2 CK is where the points are going, it helps to know exactly which domain and why. MedBoardTutors offers a free one-on-one consultation to review your score data, identify the specific pattern behind your cardiology misses, and build a plan that targets those gaps directly.
Most students leave with two or three concrete changes to make that week.
Hypertension: Urgent vs. Emergency and Resistant HTN
The board question almost always presents a patient with a blood pressure above 180/120 and asks what to do next. The pivot is whether end-organ damage is present. Getting this distinction wrong is one of the most common cardiology Step 2 CK errors, and it tends to appear in both straightforward vignettes and in more complex presentations where end-organ damage is buried in the labs or exam findings rather than stated outright.
⚠ Hypertensive Urgency
BP >180/120 — No organ damage
- Oral antihypertensives
- Gradual reduction over 24–48 hours
- No ICU. No IV agents.
- Aggressive drop causes ischemia
🚑 Hypertensive Emergency
BP >180/120 + End-organ damage
- ICU + IV titratable agents
- Reduce MAP ≤25% in first hour
- Then toward 160/100 over 2–6 h
- Encephalopathy, ACS, AKI, dissection, eclampsia
Aortic dissection requires a more aggressive target: SBP below 120 with heart rate below 60. A beta-blocker goes first, before any vasodilator, to prevent reflex tachycardia that would increase aortic wall stress. Pheochromocytoma and cocaine toxicity require an alpha-blocker (phentolamine). Never give a beta-blocker alone in these settings because unopposed alpha stimulation will worsen hypertension. In eclampsia, the target is an SBP below 140 within the first hour, using labetalol, hydralazine, or nicardipine, with magnesium sulfate for seizure prophylaxis.
Resistant hypertension, defined as blood pressure above goal despite three appropriately dosed antihypertensives including a diuretic, raises the question of secondary causes. The most commonly tested are primary hyperaldosteronism (low potassium, elevated aldosterone-to-renin ratio), renovascular hypertension (renal artery stenosis, especially in young women with fibromuscular dysplasia or older patients with diffuse atherosclerosis), and obstructive sleep apnea. Pheochromocytoma and Cushing syndrome also appear.
Congenital Heart Disease Basics for Step 2 CK
Congenital heart disease questions on Step 2 CK are less common than ACS or arrhythmia questions, but several presentations appear regularly enough to warrant review. The cardiology USMLE review emphasis here is on recognition and initial management, not surgical technique or anatomical depth.
The high-yield congenital lesions for Step 2 CK fall into two categories: left-to-right shunts (acyanotic) and right-to-left shunts (cyanotic).
VSD
L→RASD
L→RPDA
L→RTetralogy of Fallot
R→LTransposition (TGA)
PARALLELCoarctation of Aorta
OBSTRUCTIVEEisenmenger syndrome deserves specific mention because it represents an irreversible complication of an untreated left-to-right shunt. Chronic volume overload raises pulmonary vascular resistance to the point that shunt direction reverses. The patient, previously acyanotic, becomes cyanotic. At that stage, cardiac surgery is contraindicated. The clinical picture is cyanosis with clubbing in a patient with a known or unrepaired septal defect or PDA.
✓ Step 2 CK Bottom Line
Most congenital questions test recognition, not management depth. Know the murmur or physical finding, the chest X-ray pattern, and the one management step that is either urgent (prostaglandin E1 in TGA, knee-to-chest for tet spells) or contraindicated (surgery in Eisenmenger). That covers the majority of the congenital cardiology points available.
What Wastes Time on Cardiology Step 2 CK
Three patterns account for most preventable cardiology errors.
Management Sequencing Errors
The exam is built around "next best step" logic. Stabilize first, diagnose second, definitive treatment third. Students who order a confirmatory test while the patient is in cardiogenic shock, or who start a statin before giving aspirin in a STEMI, are losing points on sequencing rather than knowledge.
Not Reading What the Question Asks
"Most likely diagnosis" and "next best step" require completely different answers from the same vignette. Reading past the stem to get to the answer choices before the question has been identified is a consistent source of error.
Over-Preparing Rare Presentations
A student who can describe the ECG findings of Brugada syndrome but cannot reliably work through ACS management or AF cardioversion timing has the wrong distribution of preparation. Cardiology Step 2 CK rewards depth in the core domains more than breadth across rare diagnoses. Most students who plateau on cardiology are not missing obscure knowledge. They are applying familiar knowledge in the wrong sequence, or missing the signal in the stem that tells them which algorithm applies.